Why Tesla's Robotaxi Rollout Is Slowing Down
Tesla scaled back its robotaxi launch goals, but regulatory issues are causing further delays. Learn about the missing paperwork and why drivers are still needed in California.
Tesla scaled back its robotaxi launch goals, but regulatory issues are causing further delays. Learn about the missing paperwork and why drivers are still needed in California.
Chinese EV sales stumbled in February 2026 due to the Spring Festival holiday, with major players like BYD and XPeng seeing sharp drops. This pressures Tesla in its key China market, raising the importance of its pivot to AI, robo-taxis, and humanoid robots for future growth.
Berkshire Hathaway’s operating profit fell 29% in Q4 2025—Warren Buffett’s final quarter as CEO—driven by weak insurance results. Greg Abel will take over. No share repurchases were made.
FDA approves Ascendis Pharma's Yuviwel, the first once-weekly injection to boost growth in children 2+ with achondroplasia. Launch expected Q2 2026.